Cytosorbents Corp Contracts & Agreements

Dealer-Manager Agreement (Filed With SEC on December 9, 2024)

Form of Subscription Right Warrant Certificate (Filed With SEC on December 9, 2024)

Form of Series A Right Warrant Certificate (Filed With SEC on December 9, 2024)

Form of Series B Right Warrant Certificate (Filed With SEC on December 9, 2024)

Amendment to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (Filed With SEC on November 7, 2024)

Employment Agreement, dated August 14, 2024, by and between the Company and Mr. Peter J. Mariani (Filed With SEC on August 16, 2024)

Restricted Stock Unit Award Agreement (Inducement Award), dated as of August 14, 2024, by and between the Registrant and Peter Mariani (Filed With SEC on August 16, 2024)

Nonstatutory Option Award Agreement (Inducement Award), dated as of August 14, 2024, by and between the Registrant and Peter Mariani (Filed With SEC on August 16, 2024)

Consulting Agreement, dated August 13, 2024, by and between the Company and Ms. Kathleen P. Bloch (Filed With SEC on August 16, 2024)

Loan and Security Agreement by and among the Borrower, the Lenders and the Administrative and Collateral Agent, dated June 28, 2024 (Filed With SEC on July 5, 2024)

Supplement to the Loan and Security Agreement by and among the Borrower, the Lenders and the Administrative and Collateral Agent, dated June 28, 2024 (Filed With SEC on July 5, 2024)

Form of Warrant to Purchase Shares of Stock of CytoSorbents Corporation by and between the Company and the Lender, dated June 28, 2024 (Filed With SEC on July 5, 2024)

Form of Payment Reduction Agreement (Filed With SEC on April 3, 2024)

Form of Nonqualified Stock Option Agreement (Filed With SEC on April 3, 2024)

Form of Warrant (Filed With SEC on December 11, 2023)

Securities Purchase Agreement, dated as of December 11, 2023, by and among CytoSorbents Corporation and the investors party thereto (Filed With SEC on December 11, 2023)

Employment Agreement, dated September 18, 2023, by and between the Company and Ms. Kathleen Bloch (Filed With SEC on September 19, 2023)

Employment Agreement, dated July 10, 2023, by and between the Company and Mr. Alexander DAmico (Filed With SEC on July 19, 2023)

Consulting Agreement, dated March 31, 2023, by and between the Company and Ms. Kathleen P. Bloch (Filed With SEC on April 6, 2023)

Assignment and Assumption of Certain Royalty Rights, dated as of November 22, 2022, by and among Robert Shipley Living Trust, ROKK, LLC, and CytoSorbents Medical, Inc (Filed With SEC on March 9, 2023)

Sixth Amendment to the Amended and Restated Loan and Security Agreement, dated as of March 8, 2023, by and among CytoSorbents Corporation, CytoSorbents Medical, Inc. and Western... (Filed With SEC on March 9, 2023)

Fifth Amendment to the Amended and Restated Loan and Security Agreement, dated December 28, 2022 (Filed With SEC on December 29, 2022)

Marketing Agreement, by and between the Company and Fresenius Medical Care Deutschland GmbH, dated as of August 1, 2022 (Filed With SEC on November 3, 2022)

Description of Capital Stock of CytoSorbents Corporation (Filed With SEC on March 10, 2022)

Fourth Amendment to the Amended and Restated Loan and Security Agreement, dated January 19, 2022 (Filed With SEC on January 20, 2022)

Success Fee Letter between the Borrower and the Bank, dated January 19, 2022 (Filed With SEC on January 20, 2022)

Open Market Sale AgreementSM, dated December 30, 2021, by and between CytoSorbents Corporation and Jefferies LLC (Filed With SEC on December 30, 2021)

Lease, dated as of March 26, 2021, by and between 300 CR LLC and CytoSorbents Medical Inc (Filed With SEC on March 31, 2021)

Third Amendment to the Amended and Restated Loan and Security Agreement, dated December 4, 2020 (Filed With SEC on December 10, 2020)

Nineteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated April 16, 2020 (Filed With SEC on August 4, 2020)

Underwriting Agreement, by and among the Company and the Underwriters, dated as of July 21, 2020 (Filed With SEC on July 22, 2020)

Employment Agreement by and between the Company and Efthymios Deliargyris, M.D., dated April 12, 2020 (Filed With SEC on April 27, 2020)

Amendment No. 1 to Open Market Sale AgreementSM, dated as of April 20, 2020, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc (Filed With SEC on April 20, 2020)

Description of Capital Stock of CytoSorbents Corporation (Filed With SEC on March 5, 2020)

Separation Agreement and Release, dated December 9, 2019, by and between CytoSorbents Corporation and Dr. Eric Mortensen (Filed With SEC on December 12, 2019)

Eighteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated January 4, 2019 (Filed With SEC on August 6, 2019)

Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Phillip P. Chan (Filed With SEC on August 5, 2019)

Amended and Restated Employment Agreement, dated as of July 30 2019, by and between CytoSorbents Medical, Inc. and Vincent Capponi (Filed With SEC on August 5, 2019)

Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Kathleen P. Bloch (Filed With SEC on August 5, 2019)

First Amendment to the Amended and Restated Loan and Security Agreement (Filed With SEC on August 5, 2019)

Open Market Sale AgreementSM, dated July 9, 2019, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc (Filed With SEC on July 9, 2019)

Exclusive Distribution Agreement, dated as of December 15, 2014, by and between CytoSorbents Europe GmbH and Aferetica s.r.l (Filed With SEC on March 7, 2019)

Amendment to Exclusive Distribution Agreement, dated December 15, 2015, by and between CytoSorbents Europe GmbH and Aferetica s.r.l (Filed With SEC on March 7, 2019)

Amendment No. 1 to Sales Agreement, dated as of July 26, 2018, by and between CytoSorbents Corporation and Cantor Fitzgerald & Co (Filed With SEC on July 26, 2018)

Amended and Restated Loan and Security Agreement, dated as of March 29, 2018, by and among CytoSorbents Corporation, CytoSorbents Medical, Inc. and Western Alliance Bank (Filed With SEC on April 4, 2018)

Success Fee Letter, dated as of March 29, 2018, by and among CytoSorbents Corporation, CytoSorbents Medical, Inc. and Western Alliance Bank (Filed With SEC on April 4, 2018)

Executive Employment Agreement (Filed With SEC on May 30, 2017)

2,222,222 Shares CYTOSORBENTS CORPORATION Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 3, 2017)

AMENDED AND RESTATEDFOURTEENTH AMENDMENT TO LEASE (Filed With SEC on August 9, 2016)

CytoSorbentsCorporation, A DELAWARE CORPORATION CytoSorbEntsMedical, Inc., a delaware corporation WESTERN ALLIANCEBANK, an arizona corporation LOAN AND SECURITY AGREEMENT (Filed With SEC on July 1, 2016)

Success Fee Letter CytoSorbents Corporation 7 Deer Park Drive Suite K Monmouth Junction, NJ 08852 June 30, 2016 (Filed With SEC on July 1, 2016)

FOURTEENTH AMENDMENTTO LEASE (Filed With SEC on May 9, 2016)

CONSULTING AGREEMENT (Filed With SEC on February 9, 2016)

CytoSorbentsCorporation Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 5, 2015)

Executive Employment Agreement (Filed With SEC on July 15, 2015)

COMMENCEMENT DATE MEMORANDUM (Filed With SEC on March 31, 2015)

THIRDAMENDMENT TO LEASE (Filed With SEC on March 31, 2015)

This Distribution Agreement (“Agreement”)is entered into on this 20th day of September 2013, (“Effective Date”) by and between (Filed With SEC on March 31, 2015)

(Signature page follows) (Filed With SEC on March 31, 2015)

CYTOSORBENTS CORPORATION UNDERWRITING AGREEMENT (Filed With SEC on January 14, 2015)

CYTOSORBENTS CORPORATION UNDERWRITING AGREEMENT (Filed With SEC on December 30, 2014)

COMMON STOCK PURCHASE WARRANT For the Purchase of [ ] Shares of CommonStock of CYTOSORBENTS CORPORATION (Filed With SEC on December 30, 2014)

CYTOSORBENTS CORPORATION UNDERWRITING AGREEMENT (Filed With SEC on December 12, 2014)

COMMON STOCK PURCHASE WARRANT For the Purchase of [ ] Shares of CommonStock of CYTOSORBENTS CORPORATION (Filed With SEC on December 12, 2014)

AGREEMENT AND PLAN OF MERGER BETWEEN CYTOSORBENTS CORPORATION A NEVADA CORPORATION AND CYTOSORBENTS CORPORATION A DELAWARE CORPORATION (Filed With SEC on December 4, 2014)

CYTOSORBENTS CORPORATION PLACEMENT AGENCY AGREEMENT (Filed With SEC on March 12, 2014)

COMMON STOCK PURCHASE WARRANT CYTOSORBENTS CORPORATION (Filed With SEC on March 12, 2014)

Form of Subscription Agreement (Filed With SEC on March 12, 2014)

COMMON STOCK PURCHASE WARRANT CYTOSORBENTS CORPORATION (Filed With SEC on March 12, 2014)

COMMON STOCK PURCHASE WARRANT CYTOSORBENTS CORPORATION (Filed With SEC on February 14, 2014)

Form of Subscription Agreement (Filed With SEC on February 14, 2014)

Addendum I –Indemnification (Filed With SEC on February 14, 2014)

COMMON STOCK PURCHASE WARRANT CYTOSORBENTS CORPORATION (Filed With SEC on February 13, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 13, 2014)

Addendum I –Indemnification (Filed With SEC on February 13, 2014)

COMMON STOCK PURCHASE WARRANT CYTOSORBENTS CORPORATION (Filed With SEC on February 10, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 10, 2014)

COMMON STOCK PURCHASE WARRANT COMPANY INC. (Filed With SEC on January 28, 2014)

COMPANY INC. SECURITIES PURCHASEAGREEMENT (Filed With SEC on January 28, 2014)

Addendum I –Indemnification (Filed With SEC on January 28, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on January 7, 2014)

CONVERTIBLE NOTE (FOR DISCUSSION PURPOSESONLY – NOT FOR SOLICITATION) $ _____ Maturity Date : 12 Months from Note closingdate (Filed With SEC on October 10, 2013)

WARRANT TO PURCHASE COMMON STOCK OF CYTOSORBENTS CORPORATION (Filed With SEC on October 10, 2013)

FORM CONVERTIBLE NOTE $ _____ Maturity Date: 12 Months from Note closingdate (Filed With SEC on June 27, 2013)

WARRANT TO PURCHASE COMMON STOCK OF CYTOSORBENTS CORPORATION (Filed With SEC on June 27, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 4, 2012)

DEBENTURE PURCHASE AGREEMENT (Filed With SEC on February 17, 2012)

PURCHASE AGREEMENT (Filed With SEC on December 9, 2011)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 9, 2011)

AGREEMENT (Filed With SEC on December 9, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on June 20, 2011)

Dr. Robert Bartlett 1150 W. Medical Ctr. Dr. MSRB2 B560 Ann Arbor, MI 48109 Consulting Agreement (Filed With SEC on June 20, 2011)

CONVERTIBLE NOTE $ 1,250,000.00 Maturity Date :February 15, 2013 (Filed With SEC on February 22, 2011)

CONVERTIBLENOTE $800,000.00 MaturityDate :August __, 2012 (Filed With SEC on August 25, 2010)

PURCHASEAGREEMENT (Filed With SEC on May 10, 2010)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on May 10, 2010)

EMPLOYMENTAGREEMENT (Filed With SEC on April 15, 2010)

Dr.Robert Bartlett 1327Jones Dr. AnnArbor, MI 48105 ConsultingAgreement (Filed With SEC on April 15, 2010)

WAIVEROF RIGHTS UNDER THE CERTIFICATEOF DESIGNATION FOR THE SERIESB PREFERRED SHARES (Filed With SEC on May 13, 2009)

EMPLOYMENTAGREEMENT (Filed With SEC on February 4, 2009)

Date (Filed With SEC on January 9, 2009)

EMPLOYMENTAGREEMENT (Filed With SEC on January 9, 2009)

Dr.Robert Bartlett ConsultingAgreement (Filed With SEC on January 9, 2009)

SUBSCRIPTION AGREEMENT (Filed With SEC on July 1, 2008)

CERTIFICATE OF DESIGNATION (Filed With SEC on July 1, 2008)

AMENDMENT TO CERTIFICATE OF DESIGNATION OF SERIES A 10% CUMULATIVE CONVERTIBLE PREFERRED STOCK, $.001 PAR VALUE PER SHARE (Filed With SEC on July 1, 2008)

AGREEMENT AND CONSENT (Filed With SEC on July 1, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on July 1, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on January 7, 2008)

UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA (Filed With SEC on September 8, 2006)

AGREEMENT AND PLAN OF MERGER by and among GILDER ENTERPRISES, INC., MEDASORB ACQUISITION, INC. and MEDASORB CORPORATION June 29, 2006 TABLE OF CONTENTS (Filed With SEC on July 6, 2006)

CERTIFICATE TO SET FORTH DESIGNATIONS, VOTING POWERS, PREFERENCES, LIMITATIONS, RESTRICTIONS, AND RELATIVE RIGHTS OF SERIES A 10% CUMULATIVE CONVERTIBLE PREFERRED STOCK, $.001 PAR... (Filed With SEC on July 6, 2006)

FORM OF CLASS A COMMON STOCK PURCHASE WARRANT (Filed With SEC on July 6, 2006)

SUBSCRIPTION AGREEMENT (Filed With SEC on July 6, 2006)

2006 LONG-TERM INCENTIVE PLAN OF GILDER ENTERPRISES, INC. (Filed With SEC on July 6, 2006)

Category

Industry

Companies

Contracts

Cytosorbents Corp Contracts & Agreements